2nd Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for KNOA PHARMA
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Client
Income
$50,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 20, 2022 | $50,000 | Replaced |
| 2nd Quarter - Amendment | Oct 11, 2022 | $50,000 | Replaced |
| 2nd Quarter - Amendment | Jan 26, 2023 | $50,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Monitoring legislative and regulatory activities impacting the pharmaceutical industry
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA JOHNSON BOLLIER | — |
| BRIAN BURNS New | — |
| NADEAM ELSHAMI | — |
| EMILY FELDER | — |
| MARC LAMPKIN | — |
| WILLIAM MOSCHELLA New | PrincAssocDepAG DOJ,AsstAG DOJ,ChfLegCouns/Parliam Hs Judic Comm,ChfInvestigativeCouns Hs Judic Comm,GC Hs Rules Comm,Couns Hs Judic Comm,Couns/Parliam Hs Gov Rel Comm,SrLegAsst Rep Frank Wolf,LegAsst RepFrank Wolf,ComputerSysManager Rep Frank Wolf |
| ALFRED MOTTUR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.